Portfarma is an innovative pharmaceutical company that specializes in listing and marketing of generic pharmaceuticals. Portfarma is the leading import, consulting, marketing and distribution of high quality products in Iceland and elsewhere in Europe. It is the company's mission to promote quality of life in Iceland and the benefits to the people who need drugs to improve their wellbeing and health.
Portfarma the marketing authorization holder of proprietary medicinal products and specialists work diligently with the choice of partners in the manufacture of drugs. Portfarma has always followed the highest standards in terms of international standards and compliance with rules issued by Government of Iceland and the drug authorities in the EU.
Gateway for Batch Release and Testing of Pharmaceuticals into the EU/EEA
We offer services to companies who wish to import products into the EU/EEA and require full analytical testing and QP batch release. All services are offered under supervision of a Qualified Person, legally qualified to exercise the duties defined in Article 48 of Directive 2001/83/EC. Our batch release portfolio includes import from third countries and warehousing of your goods if needed. Analysis according to specification and current GMP and release to the EU/EEA market.
Portfarma is an Icelandic pharmaceutical company that specialises in registration, marketing and distribution of generic pharmaceuticals. The company constantly invests in research and development, and will take full advantage of future opportunities. Portfarma has an extensive sales network and the cooperation with qualified staff will enable effective market penetration, positioning the company strongly in its chosen markets.